Document is current
Any future updates will be listed below
-
Authors
Guo, Ling https://orcid.org/0009-0002-7081-8548
Kenmoe, Sebastien
Miyake, Fuyu
Chung, Alexandria https://orcid.org/0000-0001-5221-5570
Zhang, Han
Bandeira, Teresa
Caballero, Mauricio T. https://orcid.org/0000-0002-4218-5942
Casalegno, Jean-Sébastien
Fasce, Rodrigo
Giorgi, Chakhunashvili
Heikkinen, Terho
Huang, Q. Sue https://orcid.org/0000-0002-3923-5195
Katama, Esther Nyadzua
Keck, James W.
Liu, Enmei
Markic, Josko https://orcid.org/0000-0001-9469-9278
Moore, Hannah C.
Moyes, Jocelyn
Rath, Barbara A. https://orcid.org/0000-0001-5181-8417
Romero, Candice
Wang, Qianli
Werner, Marta
Yung, Chee Fu
,
Shchomak, Zakhar
Barreto, Rosário
Dvorkin, Julia
Morfin-Sherpa, Florence
Irakli, Karseladze
Khatuna, Zakhashvili
Olgha, Tarkhan-Mouravi
Wood, Tim
Mutunga, Martin
Kea, Agustus
Ren, Luo
Zang, Na
Deng, Yu
Mrcela, Dina
Sarna, Mohinder
Taye, Belaynew
Le, Huong
Wolter, Nicole
Cohen, Cheryl
Walaza, Sibongile
Obermeier, Patrick E.
Enriquez, Paula
Rodriguez, Ivan
Ploin, Dominique
Come, Horvat
Lopez, Olga
Bugueño, Andres
Cepeda, Alfonso
Desnoyers, Christine
Bressler, Sara
Scobie, Heather
Soto, Giselle
Bazan, Isabel
Hernandez, Roger
Nair, Harish https://orcid.org/0000-0002-9432-9100
Li, You https://orcid.org/0000-0002-8506-8439
,
Wang, Xin
Nohynek, Hanna
Bont, Louis
Openshaw, Peter
Pollard, Andrew
Kumar, Veena
Begier, Elizabeth
Janimak, Jim
Hendrix, Jenny
Kramer, Rolf
Molero, Eva
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (101034339)
Bill and Melinda Gates Foundation (INV-005318)
- License Information
-
More Information
Article History
Received: 13 February 2025
Accepted: 20 June 2025
First Online: 3 July 2025
Competing interests
: H.N. reports grants from the Innovative Medicines Initiative, related to the submitted work; grants from WHO, the National Institute for Health Research, Pfizer, and Icosavax; and personal fees from the Gates Foundation, Pfizer, ReViral, GSK, Merck, Icosavax, Sanofi, Novavax and AbbVie, outside the submitted work. Y.L. reports grants by GSK, MSD and WHO; and personal fees from Pfizer, MSD and WHO, outside the submitted work. C.F.Y. reports grants from National Medical Research Council Singapore and Wellcome Trust, and funding to attend conferences and honorarium from Pfizer, Sanofi, Moderna and Takeda, outside the submitted work. T.H. reports grants from EC IHI (PROMISE) consortium, personal fees from MSD, Pfizer and Sanofi, and participation on data safety monitoring boards for Sanofi, MSD, Moderna and Pfizer, outside the submitted work. J.W.K. reports grants from National Institutes of Health, Merck Sharp and Dohme Corporation, National Science Foundation, Centers for Disease Control and Prevention and Greenwall Foundation, and participation on data safety monitoring boards for Enhancing the Diabetes Prevention Program to promote weight loss among non-responders in a community-based lifestyle intervention funded by National Institute of Diabetes and Digestive and Kidney Diseases, outside the submitted work. M.T.C. reports grants from The Bill and Melinda Gates Foundation and personal fees from Sanofi, outside the submitted work. E.L. reports grants from MSD R&D (China), outside the submitted work. H.C.M. reports grants from Sanofi-Aventis Australia and Merck Sharp and Dohme Australia, and participation on data safety monitoring boards for Advisory Boards for Merck Sharp and Dohme Australia, Pfizer and Sanofi, outside the submitted work. BAR participation on data safety monitoring boards for GSK Flu treatment in infants chairing a DSMB, and hold leadership roles as the Chair of the ISIRV Epidemiology Group and as a board member of ESGREV, outside the submitted work. All other authors declare no competing interests.
